Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Lung Cancer

Free Subscription Articles published in Ann Surg Oncol Retrieve available abstracts of 182 articles: HTML format

Single Articles

October 2025
1. KHAN AA, Naeem W, Ansari M, Adebayo OW, et al
   Skeletal Muscle Gauge as a Prognosticator of Survival in Resected Early-Stage Non-small Cell Lung Cancer.
   Ann Surg Oncol. 2025 Oct 15. doi: 10.1245/s10434-025-18553.
   PubMed     Abstract available
   
   
   
2. CARR SR
   Social Vulnerability and Surgical Delays for Patients with Lung Cancer.
   Ann Surg Oncol. 2025 Oct 14. doi: 10.1245/s10434-025-18471.
   PubMed    
   
   
   
3. ZHONG G, Chen Y, Lai H, He J, et al
   ASO Visual Abstract: Beyond the Scalpel-EGFR Mutation Predicts Intraoperative Blood Loss and Transfusion Needs During Lung Cancer-Derived Spinal Metastasis Surgery : Preoperative EGFR Profiling Guides Blood Conservation Strategies.
   Ann Surg Oncol. 2025 Oct 14. doi: 10.1245/s10434-025-18557.
   PubMed    
   
   
   
4. WU S, Chen X, Zhang B, Bo E, et al
   The Survival for Pneumonectomy After Neoadjuvant Therapy in Non-small Cell Lung Cancer: A Retrospective Study from the National Cancer Center in China.
   Ann Surg Oncol. 2025 Oct 13. doi: 10.1245/s10434-025-18436.
   PubMed     Abstract available
   
   
   
5. MOTT NM, Meguid RA, Randhawa SK, David EA, et al
   ASO Visual Abstract: Social Vulnerability is Associated with Significant Delays to Definitive Surgery for Stage IA-IIIA Non-small Cell Lung Cancer and Consequential Increased Rates of Pathologic Upstaging.
   Ann Surg Oncol. 2025 Oct 7. doi: 10.1245/s10434-025-18504.
   PubMed    
   
   
   
6. LOMBARDO J, Florea IB, Toomey N, Khrizman P, et al
   The Landmark Series: Role of Curative Intent Treatment for Oligometastatic Disease of the Lung.
   Ann Surg Oncol. 2025;32:7845-7851.
   PubMed     Abstract available
   
   
   September 2025
7. MOTT NM, Meguid RA, Stuart CM
   ASO Author Reflections: Social Vulnerability and Surgical Delay in Resectable Non-small Cell Lung Cancer.
   Ann Surg Oncol. 2025 Sep 29. doi: 10.1245/s10434-025-18464.
   PubMed    
   
   
   
8. LI Z, Yang Z, Liu C
   Induction Therapy with Crizotinib Before Surgery for ROS1 Fusion-Positive Potentially Resectable Non-small Cell Lung Cancer.
   Ann Surg Oncol. 2025 Sep 27. doi: 10.1245/s10434-025-18402.
   PubMed    
   
   
   
9. ZHONG G, Chen Y, Lai H, He J, et al
   Beyond the Scalpel: EGFR Mutation Predicts Intraoperative Blood Loss and Transfusion Needs During Lung Cancer-derived Spinal Metastasis Surgery.
   Ann Surg Oncol. 2025 Sep 23. doi: 10.1245/s10434-025-18332.
   PubMed     Abstract available
   
   
   
10. MOTT NM, Meguid RA, Randhawa SK, David EA, et al
    Social Vulnerability is Associated with Significant Delays to Definitive Surgery for Stages IA to IIIA Non-small Cell Lung Cancer and Consequential Increased Rates of Pathologic Upstaging.
    Ann Surg Oncol. 2025 Sep 20. doi: 10.1245/s10434-025-18337.
    PubMed     Abstract available
    
    
    
11. LIU J, Ma H, Li D, Li Y, et al
    ASO Visual Abstract: Early Post-Discharge Pain Trajectories After Thoracoscopic Sublobar Resection for Stage IA Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Sep 17. doi: 10.1245/s10434-025-18369.
    PubMed    
    
    
    
12. SONODA D, Kondo Y, Maruyama R, Mitsuhashi S, et al
    ASO Visual Abstract: Characteristics of Patients with Non-small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 20 Q787Q Mutation.
    Ann Surg Oncol. 2025 Sep 16. doi: 10.1245/s10434-025-18366.
    PubMed    
    
    
    
13. SONODA D, Kondo Y, Maruyama R, Mitsuhashi S, et al
    ASO Author Reflections: Impact of the Epidermal Growth Factor Receptor Exon 20 Q787Q Mutation on the Clinical Course of Non-Small-Cell Lung Cancer.
    Ann Surg Oncol. 2025 Sep 10. doi: 10.1245/s10434-025-18270.
    PubMed    
    
    
    
14. XIAO W, Chen X
    ASO Author Reflections: RUNX3 in Non-Small Cell Lung Cancer Tumor Microenvironment: Bridging Mechanisms and Clinical Potential.
    Ann Surg Oncol. 2025 Sep 8. doi: 10.1245/s10434-025-18187.
    PubMed    
    
    
    
15. XIAO W, Zheng J, Deng Y, Huang B, et al
    Single-Cell RNA Sequencing Reveals Potential Mechanism of RUNX3 Reshaping Tumor Microenvironment in Non-small-cell Lung Cancer.
    Ann Surg Oncol. 2025 Sep 7. doi: 10.1245/s10434-025-18034.
    PubMed     Abstract available
    
    
    
16. CHENG JJ, Dai ZY, Wang FQ, Zhang HL, et al
    ASO Visual Abstract: Analysis of Individual Patient Data Demonstrates that Sublobar Resection Followed by Adjuvant Chemotherapy has Equivalent Prognosis to Lobectomy in Stage I Non-Small Cell Lung Cancer Patients with Spread Through Air Spaces.
    Ann Surg Oncol. 2025 Sep 5. doi: 10.1245/s10434-025-18289.
    PubMed    
    
    
    
17. LIU J, Zhou P
    ASO Author Reflections: Predictors of Unrecovered Early Post-Discharge Pain after Thoracoscopic Sublobar Resection for Stage IA Lung Cancer.
    Ann Surg Oncol. 2025 Sep 2. doi: 10.1245/s10434-025-18231.
    PubMed    
    
    
    
18. SUN J, Shen Z, Han L, Wan S, et al
    The Prognostic Significance of SMARCA4 Deficiency in Early-Stage Pulmonary Large Cell Carcinoma.
    Ann Surg Oncol. 2025;32:7049-7058.
    PubMed     Abstract available
    
    
    August 2025
19. JI Y, Cui K, Zhang J, Wang J, et al
    Noninvasive Prediction of Programmed Cell Death Protein-Ligand 1 Expression in Locally Advanced Non-small Cell Lung Cancer by (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Metabolic Habitats: A Multicenter Radiomic an
    Ann Surg Oncol. 2025 Aug 29. doi: 10.1245/s10434-025-18139.
    PubMed     Abstract available
    
    
    
20. YIKAI X, Jian Z, Zhenyu Y, Zhangyi D, et al
    ASO Author Reflections: Visible Pleural Retraction: An Underestimated Prognostic Marker for Early-Stage Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Aug 27. doi: 10.1245/s10434-025-18226.
    PubMed    
    
    
    
21. LIU J, Ma H, Li D, Li Y, et al
    Early Post-discharge Pain Trajectories After Thoracoscopic Sublobar Resection for Stage IA Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Aug 25. doi: 10.1245/s10434-025-18183.
    PubMed     Abstract available
    
    
    
22. SONODA D, Kondo Y, Maruyama R, Mitsuhashi S, et al
    Characteristics of Patients with Non-Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 20 Q787Q Mutation.
    Ann Surg Oncol. 2025 Aug 24. doi: 10.1245/s10434-025-18143.
    PubMed     Abstract available
    
    
    
23. XING Y, Zhou J, Yang Z, Dai Z, et al
    Visible Pleural Retraction is a Prognostic Marker in Early-Stage Non-Small Cell Lung Cancer: A Retrospective Cohort Study.
    Ann Surg Oncol. 2025 Aug 9. doi: 10.1245/s10434-025-17946.
    PubMed     Abstract available
    
    
    
24. UEDA D, Mimae T, Okada M
    Reply to: "Should Muscle Mass be Incorporated into Surgical Decision Making for Early-Stage Lung Cancer?", by Yan et al.
    Ann Surg Oncol. 2025 Aug 9. doi: 10.1245/s10434-025-18049.
    PubMed    
    
    
    
25. HUANG K, Li P, Wu Q, Tang X, et al
    Sleeve Lobectomy, Pulmonary Artery Plasty, and Superior Vena Cava Reconstruction for Locally Advanced Non-small Cell Lung Cancer: A Single-Center Retrospective Study.
    Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-17652.
    PubMed     Abstract available
    
    
    
26. CHENG JJ, Dai ZY, Wang FQ, Zhang HL, et al
    ASO Author Reflections: Leveraging Individual Patient Data to Refining Surgical Decision Making in Spread Through Air Spaces: Positive Stage I Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Aug 4. doi: 10.1245/s10434-025-17995.
    PubMed    
    
    
    
27. BURKHARD-MEIER A, Grube M, Jurinovic V, Agaimy A, et al
    Does Size Outweigh Number in Predicting Survival After Pulmonary Metastasectomy for Soft Tissue Sarcoma? Insights from a Retrospective Multicenter Study.
    Ann Surg Oncol. 2025;32:5948-5956.
    PubMed     Abstract available
    
    
    
28. PENG Y, Jia N, Wang J, Dong S, et al
    Analysis of Multiple Programmed Cell Death Patterns and Functional Validations of Apoptosis-Associated Genes in Lung Adenocarcinoma.
    Ann Surg Oncol. 2025;32:6005-6022.
    PubMed     Abstract available
    
    
    July 2025
29. AN Z, Yang X, Dai C
    ASO Author Reflections: Neoadjuvant Targeted Therapy in Locally Advanced Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Jul 23. doi: 10.1245/s10434-025-17882.
    PubMed    
    
    
    
30. VENUGOPAL N, Vazquez-Urrutia JR, Zhu J, Hashinokuchi A, et al
    ASO Author Reflections: Examining the Outcomes of Adding Immunotherapy to Adjuvant Chemoradiation in Pathologic Stage II-IIIB Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Jul 22. doi: 10.1245/s10434-025-17879.
    PubMed    
    
    
    
31. VENUGOPAL N, Vazquez-Urrutia JR, Zhu J, Hashinokuchi A, et al
    Lack of Survival Benefit with Immunotherapy in Combination with Adjuvant Chemoradiation in Pathologic Stage II-IIIB Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Jul 17. doi: 10.1245/s10434-025-17766.
    PubMed     Abstract available
    
    
    
32. AN Z, Yang X, Zhu Y, Zhao D, et al
    Outcomes After Neoadjuvant Targeted Therapy in Patients with ALK or ROS1 Rearrangement Locally Advanced Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Jul 8. doi: 10.1245/s10434-025-17767.
    PubMed     Abstract available
    
    
    
33. JIN X, Yan H, Tian D
    Should Muscle Mass be Incorporated into Surgical Decision-Making for Early-Stage Lung Cancer?
    Ann Surg Oncol. 2025 Jul 7. doi: 10.1245/s10434-025-17792.
    PubMed    
    
    
    
34. WU HL, Yang R, Liang XL, Ma R, et al
    Clinical Significance of Tumor-Infiltrating Lymphocytes in Malignant Peritoneal Mesothelioma: A Single-Center Study of 143 Cases.
    Ann Surg Oncol. 2025;32:5051-5062.
    PubMed     Abstract available
    
    
    
35. TANG WF, Qiu ZB, Chu XP, Zeng YM, et al
    EGFR Mutation Rates Correlate with Age at Diagnosis and Tumor Characteristics in Patients with Pulmonary Ground-Glass Opacities.
    Ann Surg Oncol. 2025;32:4641-4649.
    PubMed     Abstract available
    
    
    June 2025
36. LI P, Huang K, Wu Q, Che G, et al
    Influence of Cycles of Neoadjuvant Chemoimmunotherapy on Treatment Response in Stage IIIA-N2IIIB Non-small Cell Lung Cancer: Experience from a Large-Volume Center.
    Ann Surg Oncol. 2025 Jun 24. doi: 10.1245/s10434-025-17598.
    PubMed     Abstract available
    
    
    
37. KHAN AA, Shah SK, Basu S, Alex GC, et al
    ASO Visual Abstract: Thoracic Adipose Volume is Associated with Occult Nodal Disease- and Disease-Free Survival in Females with Clinically Node Negative Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Jun 14. doi: 10.1245/s10434-025-17634.
    PubMed    
    
    
    
38. LI Z, Wu J, Chen C, Liu C, et al
    ASO Visual Abstract: Longitudinal Trajectory of Patient-Reported Fatigue in Patients Undergoing Thoracoscopic Lung Cancer Surgery.
    Ann Surg Oncol. 2025 Jun 9. doi: 10.1245/s10434-025-17574.
    PubMed    
    
    
    
39. KHAN AA, Shah SK, Basu S, Alex GC, et al
    Thoracic Adipose Volume is Associated with Occult Nodal Disease and Disease-Free Survival in Females with Clinically Node-Negative Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Jun 3. doi: 10.1245/s10434-025-17485.
    PubMed     Abstract available
    
    
    
40. HASHINOKUCHI A, Kinoshita F, Iimori M, Kosai K, et al
    DNA Polymerase Delta 2 Activates Cell Cycle in Lung Adenocarcinoma, Leading to High Malignancy and Poor Prognosis.
    Ann Surg Oncol. 2025;32:4487-4496.
    PubMed     Abstract available
    
    
    
41. SINGH A, Xie Y, Mazzola E, Wang S, et al
    Gait Speed as a Measure of Frailty and Outcomes After Lung Resection.
    Ann Surg Oncol. 2025;32:4181-4188.
    PubMed     Abstract available
    
    
    May 2025
42. NAEEM W, Khan AA, Adebayo OW, Ansari M, et al
    ASO Visual Abstract: Difficult Decisions in the Multidisciplinary Treatment of Resectable Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 May 26. doi: 10.1245/s10434-025-17521.
    PubMed    
    
    
    
43. NAEEM W, Khan AA, Seder CW
    ASO Author Reflections: Controversies at the Tumor Board-The Gray Areas in the Multimodality Treatment of Resectable Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 May 19. doi: 10.1245/s10434-025-17459.
    PubMed    
    
    
    
44. LI Z, Wu J, Chen C, Liu C, et al
    Longitudinal Trajectory of Patient-Reported Fatigue in Patients Undergoing Thoracoscopic Lung Cancer Surgery.
    Ann Surg Oncol. 2025 May 17. doi: 10.1245/s10434-025-17444.
    PubMed     Abstract available
    
    
    
45. SU XE, Lin CL, Wang HG, Jing-Liu, et al
    Development and Validation of a Machine Learning-Based Predictive Model for Postoperative Frailty in Patients with Non-Small Cell Lung Cancer and Its Relation to Early Recovery.
    Ann Surg Oncol. 2025 May 14. doi: 10.1245/s10434-025-17353.
    PubMed     Abstract available
    
    
    April 2025
46. NAEEM W, Khan AA, Adebayo OW, Ansari M, et al
    Difficult Decisions in the Multidisciplinary Treatment of Resectable Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Apr 28. doi: 10.1245/s10434-025-17345.
    PubMed     Abstract available
    
    
    
47. UEDA D, Mimae T, Kamigaichi A, Tsubokawa N, et al
    Prognostic Benefit of Segmentectomy for Patients with Low Muscle Mass in Early-Stage Lung Cancer.
    Ann Surg Oncol. 2025 Apr 24. doi: 10.1245/s10434-024-16384.
    PubMed     Abstract available
    
    
    
48. ASAMURA H, Yotsukura M, Rami-Porta R, Rusch VW, et al
    Updates on the Version 9 American Joint Committee on Cancer Staging System for Lung Cancer.
    Ann Surg Oncol. 2025 Apr 15. doi: 10.1245/s10434-025-17327.
    PubMed    
    
    
    
49. MATSUDO K, Takada K, Hashinokuchi A, Nagano T, et al
    Significance of Tumor Microvasculature in the Tumor Microenvironment in Adenocarcinoma with EGFR Common Mutations.
    Ann Surg Oncol. 2025;32:3031-3039.
    PubMed     Abstract available
    
    
    
50. LIANG XL, Su YD, Li XB, Fu YB, et al
    Prognostic Factors of Long-Term Survival and Conditional Survival Analysis in MPM Patients Treated with CRS+HIPEC: A Retrospective Study of Two Centers.
    Ann Surg Oncol. 2025;32:2912-2922.
    PubMed     Abstract available
    
    
    
51. CHEN PH, Chen C, Lu CW, Lu TP, et al
    Tumor Spread Through Air Spaces Predicts Survival in Resected Pulmonary Lymphoepithelial Carcinoma.
    Ann Surg Oncol. 2025;32:2675-2686.
    PubMed     Abstract available
    
    
    March 2025
52. JENKINS JA, Aly MR, Farina JM, Khedr A, et al
    ASO Visual Abstract: Money Matters-The Effect of Income on Postsurgical Outcomes in Stage IA Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Mar 30. doi: 10.1245/s10434-025-17240.
    PubMed    
    
    
    
53. BANKS KC, Sarovar V, Sun A, Wile RK, et al
    ASO Visual Abstract: The Impact of Preoperative Invasive Nodal Staging on Unexpected Mediastinal Upstaging in Early Stage Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Mar 26. doi: 10.1245/s10434-025-17213.
    PubMed    
    
    
    
54. LAMPA E, Boros M, Berglund A, Wagenius G, et al
    Timing of Adjuvant Chemotherapy After Surgical Resection for Non-small Cell Lung Cancer: A Target Trial Emulation Using Nationwide Swedish Registry Data.
    Ann Surg Oncol. 2025 Mar 19. doi: 10.1245/s10434-025-17193.
    PubMed     Abstract available
    
    
    
55. JENKINS JA, Aly MR, Farina JM, Khedr A, et al
    Money Matters: The Effect of Income on Postsurgical Outcomes in Stage IA Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Mar 12. doi: 10.1245/s10434-025-17107.
    PubMed     Abstract available
    
    
    
56. MADEKA I, Mack SJ, Rshaidat H, Ishwar A, et al
    Medicaid Expansion is Associated with Differences in Local Therapy for Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Mar 5. doi: 10.1245/s10434-025-17082.
    PubMed     Abstract available
    
    
    
57. WATERS J, Molena D
    Recent Noteworthy Studies in Thoracic Oncology.
    Ann Surg Oncol. 2025;32:1610-1616.
    PubMed     Abstract available
    
    
    
58. BASKIN AS, Burapachaisri K, Guha S, Velotta JB, et al
    The Landmark Series: Advances in Preoperative Mediastinal Lymph Node Staging for Non-small Cell Lung Cancer (NSCLC).
    Ann Surg Oncol. 2025 Mar 1. doi: 10.1245/s10434-025-17008.
    PubMed     Abstract available
    
    
    February 2025
59. BANKS KC, Sarovar V, Sun A, Wile RK, et al
    The Impact of Preoperative Invasive Nodal Staging on Unexpected Mediastinal Upstaging in Early-Stage Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Feb 20. doi: 10.1245/s10434-025-17034.
    PubMed     Abstract available
    
    
    
60. BASKIN AS, Velotta JB
    ASO Author Reflections: Preoperative Mediastinal Lymph Node Staging for Non-small Cell Lung Cancer: Where Do We Go from Here?
    Ann Surg Oncol. 2025 Feb 17. doi: 10.1245/s10434-025-17035.
    PubMed    
    
    
    
61. HUANG Y, Zeng H, Zhang G, Ren F, et al
    Pooled Analysis of the Prognostic Significance of Epidermal Growth Factor Receptor (EGFR) Mutational Status in Combination with Other Driver Genomic Alterations in Stage I Resected Invasive Lung Adenocarcinoma for Recurrence-Free Survival: A Populatio
    Ann Surg Oncol. 2025;32:760-770.
    PubMed     Abstract available
    
    
    
62. KHAN MMM, Khalil M, Stecko H, Pawlik TM, et al
    Disparities in Next-Generation Genetic Sequencing Among Individuals with Cancer.
    Ann Surg Oncol. 2025;32:650-652.
    PubMed     Abstract available
    
    
    January 2025
63. MANISUNDARAM N, Ragan MV, Mayon L, Vaporciyan A, et al
    ASO Visual Abstract: Surgical Margins and Oncologic Outcomes Following Wedge Resection of Pulmonary Metastases in Pediatric and Young Adult Sarcoma Patients.
    Ann Surg Oncol. 2025 Jan 29. doi: 10.1245/s10434-025-16900.
    PubMed    
    
    
    
64. AKAMINE T, Wakasu S, Matsubara T, Yamaguchi M, et al
    ASO Visual Abstract: Is Sublobar Resection Feasible for High-Risk Pathological Stage I Non-small Cell Lung Cancer?
    Ann Surg Oncol. 2025 Jan 27. doi: 10.1245/s10434-025-16907.
    PubMed    
    
    
    
65. SIRAKAYA F, Calik Kutukcu E, Onur MR, Dikmen E, et al
    Re: The Effects of Various Approaches to Lobectomies on Respiratory Muscle Strength, Diaphragm Thickness, and Exercise Capacity in Lung Cancer Re: Enhancing Respiration Function Evaluation and Recovery in Lung Cancer: The Interdisciplinary Approach to
    Ann Surg Oncol. 2025 Jan 22. doi: 10.1245/s10434-024-16865.
    PubMed    
    
    
    
66. MANISUNDARAM N, Ragan MV, Mayon L, Vaporciyan A, et al
    Surgical Margins and Oncologic Outcomes Following Wedge Resection of Pulmonary Metastases in Pediatric and Young Adult Patients with Sarcoma.
    Ann Surg Oncol. 2025 Jan 9. doi: 10.1245/s10434-024-16800.
    PubMed     Abstract available
    
    
    
67. LI Z, He Z, Xu W, Pan X, et al
    The Necessity of Lymphadenectomy for Non-Small Cell Lung Cancer Smaller Than 6 mm in Solid Size.
    Ann Surg Oncol. 2025 Jan 9. doi: 10.1245/s10434-024-16675.
    PubMed     Abstract available
    
    
    December 2024
68. ZHANG B, Xia L, Zhu X, Zhang L, et al
    Enhancing Respiration Function Evaluation and Recovery in Lung Cancer: The Interdisciplinary Approach to Postoperative Management.
    Ann Surg Oncol. 2024 Dec 29. doi: 10.1245/s10434-024-16733.
    PubMed     Abstract available
    
    
    
69. AKAMINE T, Wakasu S, Matsubara T, Yamaguchi M, et al
    Is Sublobar Resection Feasible for High-Risk Pathologic Stage I Non-small Cell Lung Cancer?
    Ann Surg Oncol. 2024 Dec 16. doi: 10.1245/s10434-024-16700.
    PubMed     Abstract available
    
    
    
70. PACHIMATLA AG, Gee K, Hsiao HH, Yendamuri S, et al
    Image-Based Measures of Obesity are Associated with Alterations in Metabolic Pathways in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2024 Dec 13. doi: 10.1245/s10434-024-16402.
    PubMed     Abstract available
    
    
    
71. LIU J, Cao B, Shi Z, Liu X, et al
    Correlation Between the Number of Pathological Risk Factors and Postoperative Prognosis in Patients with Stage I Lung Adenocarcinoma.
    Ann Surg Oncol. 2024;31:9310-9320.
    PubMed     Abstract available
    
    
    
72. XIANG Y, Zhou K, Fang C, Han W, et al
    Impact of Tumor Size and Differentiation Grade on Survival After Lobectomy and Segmentectomy for Patients with Early-Stage Lung Adenocarcinoma.
    Ann Surg Oncol. 2024;31:9289-9297.
    PubMed     Abstract available
    
    
    November 2024
73. WEI X, Liu J, Cao B, Shi Q, et al
    Image-Based Assessment of Obesity and Metabolic Pathway Alterations in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2024 Nov 29. doi: 10.1245/s10434-024-16617.
    PubMed    
    
    
    
74. LIU W, Yue D, Zhang B
    ASO Author Reflections: The Candidate Biomarkers for Predicting Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2024 Nov 15. doi: 10.1245/s10434-024-16150.
    PubMed    
    
    
    
75. UEDA D, Mimae T, Okada M
    ASO Author Reflections: Surgical Procedures for Early-Stage Lung Cancer Patients with Low Muscle Mass.
    Ann Surg Oncol. 2024 Nov 15. doi: 10.1245/s10434-024-16481.
    PubMed    
    
    
    
76. GONG S, Li G, Wu B
    Prognostic Role of Emphysema in Surgical Stage I Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2024 Nov 8. doi: 10.1245/s10434-024-16427.
    PubMed    
    
    
    
77. KAR M
    The Impact of Sarcopenia on Outcomes in Video-Assisted Thoracoscopic Surgery (VATS) for Lung Cancer.
    Ann Surg Oncol. 2024 Nov 7. doi: 10.1245/s10434-024-16447.
    PubMed    
    
    
    
78. HONG Q, Chen H, Yi H, Mu J, et al
    Virtual Reality: Pioneering the Future of Precision in Anatomical Partial Lobectomy.
    Ann Surg Oncol. 2024;31:7665-7667.
    PubMed    
    
    
    
79. WU J, Li C, Liu C
    Uniportal Thoracoscopic Complex Combined Seg-Sub-subsegmentectomy of RS9+10bii: Dual-Display Method and Combined Approaches (Trans-fissure and Trans-ligament).
    Ann Surg Oncol. 2024;31:7775-7776.
    PubMed     Abstract available
    
    
    
80. NAKAMURA A, Hashimoto M, Kuroda A, Takegahara K, et al
    Peritoneal Dissemination in Patients with Recurrence After Post-pleurectomy/decortication for Pleural Mesothelioma.
    Ann Surg Oncol. 2024;31:7767-7774.
    PubMed     Abstract available
    
    
    October 2024
81. KAO TN, Chiang XH, Kuo SW, Huang PM, et al
    ASO Visual Abstract: Comparative Analyses of the Outcomes Between Lobectomies and Trisegmentectomies/Lingulectomies in the Surgical Management of Clinical Stage I Left Upper Lobe Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2024 Oct 31. doi: 10.1245/s10434-024-16394.
    PubMed    
    
    
    
82. KAO TN, Chiang XH, Kuo SW, Huang PM, et al
    Comparative Analyses of the Outcomes Between Lobectomies and Trisegmentectomies/Lingulectomies in the Surgical Management of Clinical Stage I Left Upper Lobe Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2024 Oct 24. doi: 10.1245/s10434-024-16338.
    PubMed     Abstract available
    
    
    
83. NAKAMURA A, Hashimoto M, Funaki S, Hasegawa S, et al
    ASO Author Reflections: Postoperative Peritoneal Dissemination Recurrence of Pleural Mesothelioma has a Poor Prognosis.
    Ann Surg Oncol. 2024;31:6729-6730.
    PubMed    
    
    
    
84. LIU J, Cao B, Shi Z, Liu X, et al
    ASO Author Reflections: Correlation between the Number of Pathological Risk Factors and Postoperative Prognosis in Patients with Stage I Lung Adenocarcinoma.
    Ann Surg Oncol. 2024;31:6727-6728.
    PubMed    
    
    
    
85. WU J, Liu C
    ASO Author Reflections: Uniportal Thoracoscopic Highly Complex Basal Segmentectomies-Demanding Techniques are Needed.
    Ann Surg Oncol. 2024;31:6720-6721.
    PubMed    
    
    
    
86. NAGANO T, Takada K, Takenaka T, Yoshizumi T, et al
    ASO Author Reflections: Relationship Between SIRPalpha Expression on Tumor-Associated Macrophages and Tumor Microenvironment in Lung Squamous Cell Carcinoma.
    Ann Surg Oncol. 2024;31:6725-6726.
    PubMed    
    
    
    
87. ROCCO G
    Predicting Lung Function After Segmentectomy.
    Ann Surg Oncol. 2024;31:6359-6360.
    PubMed    
    
    
    
88. OHTANI-KIM SJ, Samejima J, Wakabayashi M, Tada M, et al
    Effect of Resected Lung Volume on Pulmonary Function and Residual Lung Volume in Patients Undergoing Segmentectomy: A Retrospective Study.
    Ann Surg Oncol. 2024;31:6645-6651.
    PubMed     Abstract available
    
    
    September 2024
89. BRUNELLI A
    Wedge or Segmentectomy for Early-Stage Non-Small Cell Lung Cancer? The Dilemma Remains Unresolved.
    Ann Surg Oncol. 2024 Sep 23. doi: 10.1245/s10434-024-16257.
    PubMed    
    
    
    
90. LAI Y, Dong Y, Che GW
    ASO Author Reflections: Prerehabilitation with High-Intensive Model for Surgical Lung Cancer Patients.
    Ann Surg Oncol. 2024 Sep 21. doi: 10.1245/s10434-024-16151.
    PubMed    
    
    
    
91. LAI Y, Dong Y, Tian L, Li H, et al
    The Optimal Time of High-Intensity Pre-rehabilitation for Surgical Lung Cancer Patients: A Retrospective Cohort Study with 4452 Patients.
    Ann Surg Oncol. 2024 Sep 19. doi: 10.1245/s10434-024-16054.
    PubMed     Abstract available
    
    
    
92. BOUTROS CS, Arora RC, Towe CW
    Optimizing Preoperative Rehabilitation: Shaping the Future of Lung Cancer Surgery Outcomes.
    Ann Surg Oncol. 2024 Sep 17. doi: 10.1245/s10434-024-16256.
    PubMed    
    
    
    
93. LIU J, Qing H
    ASO Author Reflections: Impact of Sarcopenia on Patient-Reported Outcomes After Video-Assisted Thoracoscopic Surgery for Lung Cancer.
    Ann Surg Oncol. 2024 Sep 16. doi: 10.1245/s10434-024-16241.
    PubMed    
    
    
    
94. OHTANI-KIM SJ, Samejima J, Wakabayashi M, Tada M, et al
    ASO Visual Abstract: Effect of Resected Lung Volume on Pulmonary Function and Residual Lung Volume in Patients Undergoing Segmentectomy-A Retrospective Study.
    Ann Surg Oncol. 2024;31:5783-5784.
    PubMed    
    
    
    
95. NAGANO T, Takada K, Narutomi F, Kinoshita F, et al
    Clinical Significance of SIRPalpha Expression on Tumor-Associated Macrophages in Patients with Lung Squamous Cell Carcinoma.
    Ann Surg Oncol. 2024;31:6309-6319.
    PubMed     Abstract available
    
    
    
96. YASAR S
    ASO Author Reflections: Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights from a Multi-center Study.
    Ann Surg Oncol. 2024;31:6276-6277.
    PubMed    
    
    
    
97. OHTANI-KIM SJ, Samejima J, Wakabayashi M, Tada M, et al
    What is the Optimal Resection Extent for Preserving Respiratory Function in Segmentectomy?: Insights on Lung Resection Volume and Respiratory Function.
    Ann Surg Oncol. 2024;31:5766-5767.
    PubMed    
    
    
    
98. VAN HAREN RM, Kovacic MB, Delman AM, Pratt CG, et al
    Disparities Associated with Decision to Undergo Oncologic Surgery: A Prospective Mixed-Methods Analysis.
    Ann Surg Oncol. 2024;31:5757-5764.
    PubMed     Abstract available
    
    
    
99. JIA J, Zhang G, Wei L, Qi L, et al
    The Battle for Accuracy: Identifying the Most Effective Grading System for Lung Invasive Mucinous Adenocarcinoma.
    Ann Surg Oncol. 2024;31:5717-5728.
    PubMed     Abstract available
    
    
    
100. FUJIWARA W, Yotsukura M, Yoshida Y, Nakagawa K, et al
     Clinical and Pathologic Differences between Small-Cell Carcinoma and Large-Cell Neuroendocrine Carcinoma of the Lung.
     Ann Surg Oncol. 2024;31:5697-5705.
     PubMed     Abstract available
     
     
     
101. YASAR S, Yilmaz F, Utkan G, Algin E, et al
     Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights From a Multi-Center Study.
     Ann Surg Oncol. 2024;31:6228-6236.
     PubMed     Abstract available
     
     
     
102. SIRAKAYA F, Calik Kutukcu E, Onur MR, Dikmen E, et al
     ASO Author Reflections: Is the VATS Technique Superior to Thoracotomy Techniques in Terms of Respiratory Muscle Function and Functional Exercise Capacity?
     Ann Surg Oncol. 2024;31:5768-5769.
     PubMed    
     
     
     August 2024
103. LIU J, Li D, Ma H, Li Y, et al
     Early Postoperative Patient-Reported Outcomes of Sarcopenia Versus Nonsarcopenia in Patients Undergoing Video-Assisted Thoracoscopic Surgery for Lung Cancer.
     Ann Surg Oncol. 2024 Aug 31. doi: 10.1245/s10434-024-16140.
     PubMed     Abstract available
     
     
     
104. MOTONO N, Mizoguchi T, Ishikawa M, Iwai S, et al
     ASO Author Reflections: Utility of Sublobar Resection for Small-Sized Non-Small Cell Lung Cancer.
     Ann Surg Oncol. 2024 Aug 30. doi: 10.1245/s10434-024-16126.
     PubMed    
     
     
     
105. LIU W, Chen C, Li C, Wu X, et al
     Comprehensive Analysis of Immune Responses to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2024 Aug 27. doi: 10.1245/s10434-024-16053.
     PubMed     Abstract available
     
     
     
106. MOTONO N, Mizoguchi T, Ishikawa M, Iwai S, et al
     Accurate Selection of Sublobar Resection for Small Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2024 Aug 13. doi: 10.1245/s10434-024-16027.
     PubMed     Abstract available
     
     
     
107. TANE S
     The Crucial Value of Glutathione Peroxidase 2 to Understand the 'Two-Faced' Role of Reactive Oxygen Species in Lung Adenocarcinoma.
     Ann Surg Oncol. 2024;31:4849-4850.
     PubMed    
     
     
     
108. HASHINOKUCHI A, Matsubara T, Ono Y, Shunichi S, et al
     ASO Visual Abstract: Clinical and Prognostic Significance of Glutathione Peroxidase 2 in Lung Adenocarcinoma.
     Ann Surg Oncol. 2024;31:5098.
     PubMed    
     
     
     
109. WOO W, Park CH, Lee J, Moon DH, et al
     Left Upper Division Segmentectomy Compared with Lobectomy for Lung Expansion and Bronchus Tortuosity.
     Ann Surg Oncol. 2024;31:5021-5027.
     PubMed     Abstract available
     
     
     
110. HASHINOKUCHI A, Matsubara T, Takenaka T, Yoshizumi T, et al
     ASO Author Reflections: Impact of Glutathione Peroxidase 2 (GPX2) in Lung Adenocarcinoma.
     Ann Surg Oncol. 2024;31:5092-5093.
     PubMed    
     
     
     July 2024
111. MCGANN K, Demarest CT
     Lobectomy Versus Segmentectomy for Early-Stage Non-small Cell Lung Cancer: Is Less More?
     Ann Surg Oncol. 2024 Jul 30. doi: 10.1245/s10434-024-15883.
     PubMed    
     
     
     
112. WEI W, Wang Y, Ouyang R, Wang T, et al
     Machine Learning for Early Discrimination Between Lung Cancer and Benign Nodules Using Routine Clinical and Laboratory Data.
     Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15762.
     PubMed     Abstract available
     
     
     
113. SHAH SK, Krishnan V, Khan AA, Fass L, et al
     Women are Underrepresented in Non-small Cell Lung Cancer Clinical Trials: A Systematic Review.
     Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15720.
     PubMed     Abstract available
     
     
     
114. SHAH SK, Khan AA, Alex GC
     ASO Author Reflections: Getting a Seat at the Table-A Call for Equitable Inclusion of Women in Lung Cancer Clinical Trials.
     Ann Surg Oncol. 2024 Jul 8. doi: 10.1245/s10434-024-15778.
     PubMed    
     
     
     
115. CHEUN JH, Chung S, Han JH, Lee YW, et al
     Surveillance for Distant Metastasis in Breast Cancer Patients Who Underwent Contemporary Management: A Report from the Korean Breast Cancer Society Survivor Research Group.
     Ann Surg Oncol. 2024 Jul 5. doi: 10.1245/s10434-024-15665.
     PubMed     Abstract available
     
     
     
116. RANDLE RJ, Bhandari P, He H, Berry MF, et al
     Complications of Outpatient Chest Tube Management for Prolonged Air Leaks After Pulmonary Surgery.
     Ann Surg Oncol. 2024;31:4308-4316.
     PubMed     Abstract available
     
     
     
117. SANKARAN R, O'Connor J, Nuliyalu U, Diaz A, et al
     Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers.
     Ann Surg Oncol. 2024;31:4339-4348.
     PubMed     Abstract available
     
     
     
118. HASHINOKUCHI A, Matsubara T, Ono Y, Shunichi S, et al
     Clinical and Prognostic Significance of Glutathione Peroxidase 2 in Lung Adenocarcinoma.
     Ann Surg Oncol. 2024;31:4822-4829.
     PubMed     Abstract available
     
     
     June 2024
119. LI X, Fan F, Chen H
     ASO Author Reflections: Long-Term Follow-Up Results of Stage IA Invasive Non-Small Cell Lung Cancer Patients.
     Ann Surg Oncol. 2024 Jun 20. doi: 10.1245/s10434-024-15615.
     PubMed    
     
     
     
120. KANZAKI R, Fukuda H, Kobayashi M, Horiguchi J, et al
     ASO Visual Abstract: Pathological Pleural Invasion is a Risk Factor for Late Recurrence in Long-Term Survivors of Non-small Cell Lung Cancer After Complete Resection.
     Ann Surg Oncol. 2024 Jun 20. doi: 10.1245/s10434-024-15628.
     PubMed    
     
     
     
121. LI X, Fan F, Yang Z, Huang Q, et al
     Ten-Year Follow-Up of Lung Cancer Patients with Resected Stage IA Invasive Non-Small Cell Lung Cancer.
     Ann Surg Oncol. 2024 Jun 18. doi: 10.1245/s10434-024-15572.
     PubMed     Abstract available
     
     
     
122. BANSAL VV, Mitchell O, Drazer MW, Kindler HL, et al
     ASO Author Reflections: Venous Thromboembolism in Peritoneal Mesothelioma.
     Ann Surg Oncol. 2024;31:3785-3786.
     PubMed    
     
     
     
123. KOTI S, Demyan L, Deutsch G, Weiss M, et al
     Surgery for Oligometastatic Pancreatic Cancer: Defining Biologic Resectability.
     Ann Surg Oncol. 2024;31:4031-4041.
     PubMed     Abstract available
     
     
     
124. SHARMA J, Deo SVS, Kumar S, Bhoriwal S, et al
     Malignant Chest Wall Tumors: Complex Defects and Their Management-A Review of 181 Cases.
     Ann Surg Oncol. 2024;31:3675-3683.
     PubMed     Abstract available
     
     
     May 2024
125. AL-KASSPOOLES M, Wilkerson J
     Is Radiomics Ready for Prime Time in Managing Non-small Cell Lung Cancer?
     Ann Surg Oncol. 2024 May 18. doi: 10.1245/s10434-024-15406.
     PubMed    
     
     
     
126. ISHIDA M, Mimae T, Kamigaichi A, Kawamoto N, et al
     The Role of Emphysema on Postoperative Prognosis in Early-Stage Nonsmall Cell Lung Cancer.
     Ann Surg Oncol. 2024 May 13. doi: 10.1245/s10434-024-15126.
     PubMed     Abstract available
     
     
     
127. DENG HY, Zhou Q
     Pleural Invasion in Non-small Cell Lung Cancer: An Important Characteristic during Clinical Decision-Making.
     Ann Surg Oncol. 2024 May 8. doi: 10.1245/s10434-024-15401.
     PubMed    
     
     
     
128. ISHIDA M, Mimae T, Okada M
     ASO Author Reflections: How Does Emphysema Contribute to Poor Prognosis After Lung Cancer Surgery?
     Ann Surg Oncol. 2024 May 8. doi: 10.1245/s10434-024-15171.
     PubMed    
     
     
     
129. APRILE V, Ambrogi MC, Lucchi M
     Surgery in Stage IV Non-small Cell Lung Cancer: Good Time for a Chance.
     Ann Surg Oncol. 2024 May 6. doi: 10.1245/s10434-024-15308.
     PubMed    
     
     
     
130. YAN HJ, Zhao JS, Liu Q, Yang C, et al
     ASO Author Reflections: The Clinical Use of Dual-Region Radiomics-Based Machine Learning in the Identification of Subcarinal Lymph Node Metastasis of Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2024 May 6. doi: 10.1245/s10434-024-15271.
     PubMed    
     
     
     
131. BANSAL VV, Mitchell O, Bregio C, Witmer HDD, et al
     Venous Thromboembolism in Peritoneal Mesothelioma: Uncovering the Hidden Risk.
     Ann Surg Oncol. 2024;31:3339-3349.
     PubMed     Abstract available
     
     
     
132. GRAUR A, Saenger JA, Mercaldo ND, Simon J, et al
     Multimodality Management of Thoracic Tumors: Initial Experience With a Multidisciplinary Thoracic Ablation Conference.
     Ann Surg Oncol. 2024;31:3426-3436.
     PubMed     Abstract available
     
     
     April 2024
133. SIRAKAYA F, Calik Kutukcu E, Onur MR, Dikmen E, et al
     The Effects of Various Approaches to Lobectomies on Respiratory Muscle Strength, Diaphragm Thickness, and Exercise Capacity in Lung Cancer.
     Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15312.
     PubMed     Abstract available
     
     
     
134. KANZAKI R, Fukuda H, Kobayashi M, Horiguchi J, et al
     Pathological Pleural Invasion is a Risk Factor for Late Recurrence in Long-Term Survivors of Non-small Cell Lung Cancer after Complete Resection.
     Ann Surg Oncol. 2024 Apr 22. doi: 10.1245/s10434-024-15279.
     PubMed     Abstract available
     
     
     
135. LIU J, Shi Z, Cao B, Wang Z, et al
     ASO Author Reflections: The Prognostic Significance of the Highest Mediastinal Lymph Node Involvement in Non-small Cell Lung Cancer Patients.
     Ann Surg Oncol. 2024 Apr 4. doi: 10.1245/s10434-024-15243.
     PubMed    
     
     
     
136. SARVESTANI AL, Lambdin J, Hu M, Cabanillas M, et al
     Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancers.
     Ann Surg Oncol. 2024;31:2202-2203.
     PubMed    
     
     
     
137. CHATTERJEE A, Kusamura S, Baratti D, Guaglio M, et al
     ASO Author Reflections: Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma treated with CRS-HIPEC.
     Ann Surg Oncol. 2024;31:2511-2512.
     PubMed    
     
     
     
138. SHIKANAI S, Yamada N, Yanagawa N, Sugai M, et al
     ASO Visual Abstract: Prognostic Impact of Tumor-Associated Macrophage-Related Markers in Patients with Adenocarcinoma of the Lung.
     Ann Surg Oncol. 2024;31:2521-2522.
     PubMed    
     
     
     March 2024
139. YAN HJ, Zhao JS, Zuo HD, Zhang JJ, et al
     Dual-Region Computed Tomography Radiomics-Based Machine Learning Predicts Subcarinal Lymph Node Metastasis in Patients with Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2024 Mar 23. doi: 10.1245/s10434-024-15197.
     PubMed     Abstract available
     
     
     
140. LIU J, Shi Z, Cao B, Wang Z, et al
     Prognostic Significance of the Highest Mediastinal Lymph Node Involvement in Patients with Stage III-N2 Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2024 Mar 23. doi: 10.1245/s10434-024-15184.
     PubMed     Abstract available
     
     
     
141. GRENDA TR
     Refocusing the Prognosis Lens: Conditional Survival After Surgery in Limited-Stage Small Cell Lung Cancer.
     Ann Surg Oncol. 2024 Mar 21. doi: 10.1245/s10434-024-15168.
     PubMed    
     
     
     
142. PARK S, Choe J, Lee SM, Choi S, et al
     ASO Visual Abstract: Surgical Outcomes in Non-small Cell Lung Cancer with Distant Metastasis: The Prognostic Significance of Delayed Metastasis Diagnosis.
     Ann Surg Oncol. 2024 Mar 14. doi: 10.1245/s10434-024-15135.
     PubMed    
     
     
     
143. LIN MW, Chen LW, Yang SM, Hsieh MS, et al
     ASO Visual Abstract: CT-Based Deep Learning Model for Spread Through Air Spaces Prediction in Ground-Glass Predominant Lung Adenocarcinoma.
     Ann Surg Oncol. 2024;31:1597-1598.
     PubMed    
     
     
     
144. YOON DW, Hwang S, Hong TH, Choi YL, et al
     ASO Visual Abstract: Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary Spread.
     Ann Surg Oncol. 2024;31:1591-1592.
     PubMed    
     
     
     
145. PAN H, Huang J, Luo Q
     ASO Author Reflections: Should We Prefer Robotic over Thoracoscopic Surgery for Sublobar Resection in Octogenarians with Pulmonary Nodules
     Ann Surg Oncol. 2024;31:1585-1586.
     PubMed    
     
     
     
146. LIN MW, Chen LW, Yang SM, Hsieh MS, et al
     CT-Based Deep-Learning Model for Spread-Through-Air-Spaces Prediction in Ground Glass-Predominant Lung Adenocarcinoma.
     Ann Surg Oncol. 2024;31:1536-1545.
     PubMed     Abstract available
     
     
     February 2024
147. LIN JP, Liu SY, Wang F
     ASO Author Reflections: Conditional Survival of Patients with Limited-Stage Small Cell Lung Cancer After Surgery-A National Real-World Cohort Study.
     Ann Surg Oncol. 2024 Feb 23. doi: 10.1245/s10434-024-15062.
     PubMed    
     
     
     
148. PARK S, Choe J, Lee SM, Choi S, et al
     Surgical Outcomes in Non-Small Cell Lung Cancer with Distant Metastasis: The Prognostic Significance of Delayed Metastasis Diagnosis.
     Ann Surg Oncol. 2024 Feb 22. doi: 10.1245/s10434-024-14984.
     PubMed     Abstract available
     
     
     
149. LIN JP, Chen XF, Wang P, He H, et al
     Conditional Survival of Patients with Limited-Stage Small Cell Lung Cancer After Surgery: A National Real-World Cohort Study.
     Ann Surg Oncol. 2024 Feb 9. doi: 10.1245/s10434-024-14983.
     PubMed     Abstract available
     
     
     
150. XU SJ, Chen C, Tu JH, You CX, et al
     ASO Visual Abstract: Dynamic Analysis of the Impact of Micropapillary Component on Different Recurrence Patterns of Pathological Stage IA3 Lung Adenocarcinoma-A Multicenter, Retrospective Study.
     Ann Surg Oncol. 2024;31:906-907.
     PubMed    
     
     
     
151. XU SJ, Chen C, Tu JH, You CX, et al
     Dynamic Analysis of the Impact of Micropapillary Component on Different Recurrence Patterns of Pathological Stage IA3 Lung Adenocarcinoma: A Multicenter, Retrospective Study.
     Ann Surg Oncol. 2024;31:872-882.
     PubMed     Abstract available
     
     
     January 2024
152. KAZZI B, Mankuzhy NP, Swami N, Jain B, et al
     Surgical Resection Delays among Patients with Stage 1 Lung Cancer: A Study with Disaggregated Ethnic Groups.
     Ann Surg Oncol. 2024 Jan 28. doi: 10.1245/s10434-024-14952.
     PubMed    
     
     
     
153. OKUYAMA A, Mizutani T, Tachibana K, Higashi T, et al
     ASO Visual Abstract: Treatment Patterns and Postoperative Activities of Daily Living in Patients with Non-small Cell Lung Cancer-A Retrospective Study Using Nationwide Health Services Utilization Data in Japan.
     Ann Surg Oncol. 2024 Jan 24. doi: 10.1245/s10434-024-14928.
     PubMed    
     
     
     
154. CHATTERJEE A, Kusamura S, Baratti D, Guaglio M, et al
     Impact of Perioperative Systemic Chemotherapy on Survival for Patients Who have Diffuse Malignant Peritoneal Mesothelioma Treated with CRS-HIPEC.
     Ann Surg Oncol. 2024;31:556-566.
     PubMed     Abstract available
     
     
     
155. LI W, Yang Y, Yang M, Song N, et al
     Clinicopathologic Features and Survival Outcomes of Primary Lung Mucinous Adenocarcinoma Based on Different Radiologic Subtypes.
     Ann Surg Oncol. 2024;31:167-177.
     PubMed     Abstract available
     
     
     
156. WOODARD GA, Cho C, Chen L
     Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis?
     Ann Surg Oncol. 2024;31:25-27.
     PubMed    
     
     
     
157. YANG X, Xiao Y, Hu H, Qiu ZB, et al
     ASO Visual Abstract: Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules-A Large Study of 2022 Cases in China.
     Ann Surg Oncol. 2024;31:245-246.
     PubMed    
     
     
     
158. YOON DW, Hwang S, Hong TH, Choi YL, et al
     Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary Spread.
     Ann Surg Oncol. 2024;31:201-212.
     PubMed     Abstract available
     
     
     December 2023
159. MI J, Li C, Yang F, Shi X, et al
     ASO Visual Abstract: Comparative Study of Indocyanine Green Fluorescence Imaging in Lung Cancer with Near-Infrared-I/II Windows.
     Ann Surg Oncol. 2023 Dec 26. doi: 10.1245/s10434-023-14795.
     PubMed    
     
     
     
160. PAN H, Zou N, Tian Y, Shen Y, et al
     ASO Visual Abstract: Robotic Versus Thoracoscopic Sub-lobar Resection for Octogenarians with Clinical IA-Stage Non-small Cell Lung Cancer: A Propensity Score-Matched Real-World Study.
     Ann Surg Oncol. 2023 Dec 22. doi: 10.1245/s10434-023-14799.
     PubMed    
     
     
     
161. OKUYAMA A, Mizutani T, Tachibana K, Higashi T, et al
     Treatment Patterns and Postoperative Activities of Daily Living in Patients with Non-small Cell Lung Cancer: A Retrospective Study Using Nationwide Health Services Utilization Data in Japan.
     Ann Surg Oncol. 2023 Dec 21. doi: 10.1245/s10434-023-14798.
     PubMed     Abstract available
     
     
     
162. DIAO H, Xu L, Li X, Wang Y, et al
     Comparison Results of Three-Port Robot-Assisted and Uniportal Video-Assisted Lobectomy for Functional Recovery Index in the Treatment of Early Stage Non-small Cell Lung Cancer: A Propensity Score-Matched Analysis.
     Ann Surg Oncol. 2023 Dec 17. doi: 10.1245/s10434-023-14767.
     PubMed     Abstract available
     
     
     
163. PAN H, Zou N, Tian Y, Shen Y, et al
     Robotic Versus Thoracoscopic Sub-lobar Resection for Octogenarians with Clinical Stage IA Non-small Cell Lung Cancer: A Propensity Score-Matched Real-World Study.
     Ann Surg Oncol. 2023 Dec 10. doi: 10.1245/s10434-023-14689.
     PubMed     Abstract available
     
     
     
164. MI J, Li C, Yang F, Shi X, et al
     Comparative Study of Indocyanine Green Fluorescence Imaging in Lung Cancer with Near-Infrared-I/II Windows.
     Ann Surg Oncol. 2023 Dec 8. doi: 10.1245/s10434-023-14677.
     PubMed     Abstract available
     
     
     
165. KINOSHITA F, Takada K, Wakasu S, Saito S, et al
     ASO Visual Abstract: Granzyme B (GZMB)-Positive Tumor-Infiltrating Lymphocytes in Lung Adenocarcinoma: Significance as a Prognostic Factor and Association With Immunosuppressive Proteins.
     Ann Surg Oncol. 2023;30:8290-8291.
     PubMed    
     
     
     November 2023
166. MACHADO PFA, Oliveiros B, Martins RA, Cruz J, et al
     ASO Author Reflections: Impact of a Preoperative Home-Based Exercise Program on Quality of Life After Lung Cancer Resection.
     Ann Surg Oncol. 2023 Nov 19. doi: 10.1245/s10434-023-14620.
     PubMed    
     
     
     
167. MACHADO PFA, Pimenta S, Garcia AL, Nogueira T, et al
     ASO Visual Abstract: Effect of Preoperative Home-Based Exercise Training on Quality of Life After Lung Cancer Surgery: A Multicenter Randomized Controlled Trial.
     Ann Surg Oncol. 2023 Nov 17. doi: 10.1245/s10434-023-14602.
     PubMed    
     
     
     
168. MACHADO P, Pimenta S, Garcia AL, Nogueira T, et al
     Effect of Preoperative Home-Based Exercise Training on Quality of Life After Lung Cancer Surgery: A Multicenter Randomized Controlled Trial.
     Ann Surg Oncol. 2023 Nov 7. doi: 10.1245/s10434-023-14503.
     PubMed     Abstract available
     
     
     
169. YANG X, Xiao Y, Hu H, Qiu ZB, et al
     Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules: A Large Study of 2022 Cases in China.
     Ann Surg Oncol. 2023;30:7400-7411.
     PubMed     Abstract available
     
     
     
170. KEPENEKIAN V, Sgarbura O, Marchal F, Villeneuve L, et al
     ASO Author Reflections: International Standardization of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Protocols-Malignant Peritoneal Mesothelioma as a Model.
     Ann Surg Oncol. 2023;30:7858-7859.
     PubMed    
     
     
     
171. VILLENA-VARGAS J
     Sowing the Seeds of Evasion: Lung Adenocarcinoma Plans Its Escape.
     Ann Surg Oncol. 2023;30:6972-6973.
     PubMed    
     
     
     
172. KEPENEKIAN V, Sgarbura O, Marchal F, Villeneuve L, et al
     2022 PSOGI Consensus on HIPEC Regimens for Peritoneal Malignancies: Diffuse Malignant Peritoneal Mesothelioma.
     Ann Surg Oncol. 2023;30:7803-7813.
     PubMed     Abstract available
     
     
     
173. KOSAI K, Masuda T, Kitagawa A, Tobo T, et al
     Transducin Beta-Like 2 is a Potential Driver Gene that Adapts to Endoplasmic Reticulum Stress to Promote Tumor Growth of Lung Adenocarcinoma.
     Ann Surg Oncol. 2023;30:7538-7548.
     PubMed     Abstract available
     
     
     
174. SHIKANAI S, Yamada N, Yanagawa N, Sugai M, et al
     Prognostic Impact of Tumor-Associated Macrophage-Related Markers in Patients with Adenocarcinoma of the Lung.
     Ann Surg Oncol. 2023;30:7527-7537.
     PubMed     Abstract available
     
     
     October 2023
175. RUCK JM, Broderick SR
     Neoadjuvant and Adjuvant Pembrolizumab for the Treatment of Early-Stage Resectable Non-small Cell Lung Cancer An Editorial Regarding the Interim Data Analysis of the KEYNOTE-671 Phase III Trial of Neoadjuvant and Adjuvant Pembrolizumab.
     Ann Surg Oncol. 2023 Oct 26. doi: 10.1245/s10434-023-14356.
     PubMed    
     
     
     
176. SWANSON SJ
     Difficulty of Video-Assisted Thoracoscopic Surgery Segmentectomy: Proposal for a New Classification System-All "Segmentectomies" Are Not Created Equal.
     Ann Surg Oncol. 2023;30:6315.
     PubMed    
     
     
     
177. YAO F, Wu W, Zhu Q, Zhu Y, et al
     ASO Visual Abstract: Difficulty of Video-Assisted Thoracoscopic Surgery Segmentectomy: Proposal for a New Classification.
     Ann Surg Oncol. 2023;30:6717.
     PubMed    
     
     
     
178. ALEXANDER HR
     Perioperative Systemic Chemotherapy in Patients with Malignant Peritoneal Mesothelioma Undergoing Cytoreduction and HIPEC: Don't Put the Cart Before the Horse.
     Ann Surg Oncol. 2023;30:6301-6303.
     PubMed    
     
     
     
179. YAO F, Wu W, Zhu Q, Zhu Y, et al
     Difficulty of Video-Assisted Thoracoscopic Surgery Segmentectomy: Proposal for a New Classification.
     Ann Surg Oncol. 2023;30:6707-6716.
     PubMed     Abstract available
     
     
     September 2023
180. MATSUDA N, Yamamoto H, Habu T, Iwata K, et al
     ASO Visual Abstract: Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma.
     Ann Surg Oncol. 2023 Sep 27. doi: 10.1245/s10434-023-14311.
     PubMed    
     
     
     
181. FU F, Zhang Y, Chen H
     ASO Author Reflections: Upfront Surgery Followed by Adjuvant Therapy: An Option for IIIA-N2 Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2023 Sep 27. doi: 10.1245/s10434-023-14265.
     PubMed    
     
     
     
182. MATSUDA N, Yamamoto H, Habu T, Iwata K, et al
     Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma.
     Ann Surg Oncol. 2023 Sep 1. doi: 10.1245/s10434-023-14176.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.